Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia

Cytopathology

Volumn 20, Issue 1, 2009, Pages 27-35

  Aerssens, A ^b   Claeys, P ^a,b   Beerens, E ^a   Garcia, A ^c   Weyers, S ^a   Van Renterghem, L ^a   Praet, M ^a   Temmerman, M ^a,b   Velasquez, R ^c   Cuvelier, C A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE NICARAGUA   (Nicaragua)

Author keywords

CIN; Cytodiagnosis; Cytology; Follow up; Human papillomavirus; Prediction; Recurrent disease

Indexed keywords

ADULT; ARTICLE; BELGIUM; COLPOSCOPY; CYTOLOGY; ELECTROSURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; NICARAGUA; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; ELECTROSURGERY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VAGINAL SMEARS; YOUNG ADULT;

EID: 58149327023     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2008.00567.x     Document Type: Article

References (29)

1. Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007 18 : 581 92.
2. Monsonego J, Bosch FX, Coursaget P et al. Cervical cancer control, priorities and new directions. Int J Cancer 2004 108 : 329 33.
3. Cuschieri KS, Cubie HA, Whitley MW et al. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol 2005 58 : 946 50.
4. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999 189 : 12 9.
5. Cuschieri KS, Cubie HA. The role of human papillomavirus testing in cervical screening. J Clin Virol 2005 32 (Suppl. 1 S34 42.
6. Ho GY, Burk RD, Klein S et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995 87 : 1365 71.
7. Mitchell MF, Tortolero-Luna G, Cook E et al. A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1998 92 : 737 44.
8. Nuovo G, Moritz J, Kowalik A et al. Human papillomavirus types and cervical squamous intraepithelial lesions that recur after cold-knife conization. Gynecol Oncol 1992 46 : 304 8.
9. Bollen LJ, Tjong AHSP, van der Velden J et al. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecol Oncol 1999 72 : 199 201.
10. Bigrigg A, Haffenden DK, Sheehan AL, Codling BW, Read MD. Efficacy and safety of large-loop excision of the transformation zone. Lancet 1994 343 : 32 4.
11. Ewies AA, Sant Cassia LJ. A review of the treatment failures following cervical intraepithelial neoplasia grade III treated by large loop excision of the transformation zone. J Obstet Gynaecol 2000 20 : 399 402.
12. Spires SE, Banks ER, Weeks JA, Banks HW, Davey DD. Assessment of cervicovaginal smear adequacy. The Bethesda System guidelines and reproducibility. Am J Clin Pathol 1994 102 : 354 9.
13. Kleter B, van Doorn LJ, Schrauwen L et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999 37 : 2508 17.
14. Hindryckx P, Garcia A, Claeys P et al. Prevalence of high risk human papillomavirus types among Nicaraguan women with histological proved pre-neoplastic and neoplastic lesions of the cervix. Sex Transm Infect 2006 82 : 334 6.
15. Elfgren K, Jacobs M, Walboomers JM, Meijer CJ, Dillner J. Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia. Obstet Gynecol 2002 100 : 965 71.
16. Nobbenhuis MA, Meijer CJ, van den Brule AJ et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 2001 84 : 796 801.
17. Sarian LO, Derchain SF, Andrade LA et al. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia. Gynecol Oncol 2004 94 : 181 6.
18. Alonso I, Torne A, Puig-Tintore LM et al. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol 2006 103 : 631 6.
19. Zielinski GD, Bais AG, Helmerhorst TJ et al. HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis. Obstet Gynecol Surv 2004 59 : 543 53.
20. Cecchini S, Carozzi F, Confortini M, Zappa M, Ciatto S. Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure. Tumori 2004 90 : 225 8.
21. Verguts J, Bronselaer B, Donders G et al. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. BJOG 2006 113 : 1303 7.
22. Bornstein J, Schwartz J, Perri A, Harroch J, Zarfati D. Tools for post LEEP surveillance. Obstet Gynecol Surv 2004 59 : 663 8.
23. Paraskevaidis E, Arbyn M, Sotiriadis A et al. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev 2004 30 : 205 11.
24. Hernadi Z, Szoke K, Sapy T et al. Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions. Eur J Obstet Gynecol Reprod Biol 2005 118 : 229 34.
25. Chao A, Lin CT, Hsueh S et al. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am J Obstet Gynecol 2004 190 : 1046 51.
26. Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 2005 99 (3 Suppl. 1 S7 11.
27. Coupe VM, Berkhof J, Verheijen RH, Meijer CJ. Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia. BJOG 2007 114 : 416 24.
28. Munoz N, Bosch FX. Cervical cancer and human papillomavirus: epidemiological evidence and perspectives for prevention. Salud Publica Mex 1997 39 : 274 82.
29. Castle PE, Stoler MH, Solomon D, Schiffman M. The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol 2007 127 : 805 15.